Dimensional Fund Advisors’s Co-Diagnostics CODX Stock Holding History

Dimensional Fund Advisors’s Portfolio CODX Stock Details CODX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-351	Closed	-$13.2K	–	3345
2024 Q3	$13.2K	Hold	351	–	–	﹤0.01%	3343
2024 Q2	$13.2K	Hold	351	–	–	﹤0.01%	3360
2024 Q1	$11.8K	Hold	351	–	–	﹤0.01%	3382
2023 Q4	$14K	Hold	351	–	–	﹤0.01%	3401
2023 Q3	$11.2K	Hold	351	–	–	﹤0.01%	3459
2023 Q2	$11.7K	Sell	351 -1,064	-75%	-$40.7K	﹤0.01%	3469
2023 Q1	$62.8K	Buy	1,415 +1,063	+302%	+$85.2K	﹤0.01%	3366
2022 Q4	$27	Buy	352 +1	+0.3%	+$94	﹤0.01%	3442
2022 Q3	$34K	Hold	351	–	–	﹤0.01%	3438
2022 Q2	$59K	Sell	351 -320	-48%	-$48.7K	﹤0.01%	3380
2022 Q1	$124K	Sell	671 -2	-0.3%	-$414	﹤0.01%	3372
2021 Q4	$180K	Buy	+673	New	+$177K	﹤0.01%	3360

Other funds holding CODX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAG

Private Advisory Group Redmond, Washington $1.52B AUM 41.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors's CODX Position: Q4 2024 in Review

Dimensional Fund Advisors sold out of Co-Diagnostics (CODX) in Q4 2024, closing a stake of 351 shares — an estimated $13.2K sold.

Dimensional Fund Advisors first reported a position in CODX in Q4 2021 and held it in 12 quarters. The position peaked at $180K in Q4 2021. 37 funds tracked by Wall St. Rank hold CODX as of Q4 2024.

Dimensional Fund Advisors reported no remaining Co-Diagnostics position as of Q4 2024 after selling out during the quarter.
Dimensional Fund Advisors sold 351 Co-Diagnostics shares in Q4 2024, an estimated $13.2K.
Dimensional Fund Advisors first reported a position in Co-Diagnostics in Q4 2021 and held it in 12 quarters.
Dimensional Fund Advisors's Co-Diagnostics position peaked at $180K in Q4 2021.
37 funds tracked by Wall St. Rank held Co-Diagnostics as of Q4 2024.

Based on Dimensional Fund Advisors's 13F filing for Q4 2024, filed 13 Feb 2025.